AS Chandrabhatla, IJ Pomeraniec… - NPJ digital …, 2022 - nature.com
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor impairments such as tremor, bradykinesia, dyskinesia, and gait abnormalities. Current …
The unfolding coronavirus disease 2019 (COVID-19) pandemic is transforming neurological care more than any other crisis in modern history. Social distancing and quarantine have cut …
Mobile health technologies (wearable, portable, body-fixed sensors, or domestic-integrated devices) that quantify mobility in unsupervised, daily living environments are emerging as …
Parkinson's disease (PD) is a neurodegenerative disorder that produces both motor and non- motor complications, degrading the quality of life of PD patients. Over the past two decades …
Background Artificial intelligence (AI) has revolutionized health care delivery in recent years. There is an increase in research for advanced AI techniques, such as deep learning, to build …
Chronic neurological diseases are the leading cause of disability globally. Yet, our health- care systems are not designed to meet the needs of many patients with chronic neurological …
Digital health technologies enable remote and therefore frequent measurement of motor signs, potentially providing reliable and valid estimates of motor sign severity and …
K McFarthing, S Buff, G Rafaloff… - Journal of …, 2020 - content.iospress.com
Background: The majority of current pharmacological treatments for Parkinson's disease (PD) were approved for clinical use in the second half of the last century and they only …
DL Price, A Khan, R Angers, A Cardenas… - npj Parkinson's …, 2023 - nature.com
Direct targeting of alpha-synuclein (ASYN) has emerged as a disease-modifying strategy for Parkinson's disease and other synucleinopathies which is being approached using both …